Turkish Journal of Medical Sciences
Volume 50

Number 8

Article 22

1-1-2020

A novel Turkish instrument for assessing quality of life in chronic
otitis media -translation and validation of Zurich chronic middle
ear inventory
BELGİN TUTAR
ZİYA SALTÜRK
GÜLER BERKİTEN
MUHAMMET ENİS EKİNCİOĞLU
SEMİH KARAKETİR

See next page for additional authors

Follow this and additional works at: https://journals.tubitak.gov.tr/medical
Part of the Medical Sciences Commons

Recommended Citation
TUTAR, BELGİN; SALTÜRK, ZİYA; BERKİTEN, GÜLER; EKİNCİOĞLU, MUHAMMET ENİS; KARAKETİR,
SEMİH; ARKAN, MELİS ECE; AKGÜN, MUHAMMED FATİH; YILMAZER, AYÇA BAŞKADEM; KULAK, ERCAN;
BAECHİNGER, DAVİD; and UYAR, YAVUZ (2020) "A novel Turkish instrument for assessing quality of life in
chronic otitis media -translation and validation of Zurich chronic middle ear inventory," Turkish Journal of
Medical Sciences: Vol. 50: No. 8, Article 22. https://doi.org/10.3906/sag-2003-38
Available at: https://journals.tubitak.gov.tr/medical/vol50/iss8/22

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Medical Sciences by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

A novel Turkish instrument for assessing quality of life in chronic otitis media
-translation and validation of Zurich chronic middle ear inventory
Authors
BELGİN TUTAR, ZİYA SALTÜRK, GÜLER BERKİTEN, MUHAMMET ENİS EKİNCİOĞLU, SEMİH KARAKETİR,
MELİS ECE ARKAN, MUHAMMED FATİH AKGÜN, AYÇA BAŞKADEM YILMAZER, ERCAN KULAK, DAVİD
BAECHİNGER, and YAVUZ UYAR

This article is available in Turkish Journal of Medical Sciences: https://journals.tubitak.gov.tr/medical/vol50/iss8/22

Turkish Journal of Medical Sciences

Turk J Med Sci
(2020) 50: 1922-1929
© TÜBİTAK
doi:10.3906/sag-2003-38

http://journals.tubitak.gov.tr/medical/

Research Article

A novel Turkish instrument for assessing quality of life in chronic otitis media –
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Background/aim: The Zurich Chronic Middle Ear Questionnaire (ZCMEI-21) is a newly-developed German-language questionnaire.
The purpose of this study was to analyze the quality of life (QoL) of chronic otitis media (COM) patients and translate, transculturally
adapt, and validate the ZCMEI-21 into Turkish.
Materials and methods: Based on internationally accepted guidelines, the ZCMEI-21 was translated into Turkish. To assess its validity,
the total score of the ZCMEI-21-Tur was compared to the scores taken from the original validation study and a question that was
directly related to the health-related QoL (HRQoL), as well as the general criterion EQ-5D-5L. Questionnaires were completed by
healthy volunteers and the results were evaluated statistically.
Results: A total of 80 COM patients and 40 healthy volunteers were prospectively enrolled in this study. Regarding internal consistency,
the questionnaire showed a Cronbach α of 0.94, which indicated high internal consistency. Moreover, internal consistency was also
determined to be excellent for the Cronbach α of the individual subscales, as follows: ear sign symptoms, 0.79; hearing, 0.83; psychosocial
impact, 0.91, and medical resources, 0.84.
Conclusions: The ZCMEI-21 was translated into Turkish and validated. Therefore, the ZCMEI-21-Tur was suitable for use in assessing
HRQoL in adult patients with COM.
Key words: ZCMEI-21, chronic otitis media, quality of life, Turkish

1. Introduction
Chronic otitis media (COM) affects approximately 2% of
the population. Otorrhea, hearing loss, tinnitus, vertigo,
and malodorous discharge are serious problems in
patients with COM. In particular, hearing loss and odorrelated problems may cause problems for the patient when
communicating with their environment and consequently,
problems in education, and professional and social life [1].
Like many other chronic diseases, COM is a triggering
factor for chronic stress and psychological problems. The
parameters used for evaluation in diagnosis and the choice
of treatment are related to the disease, but do not reflect
the personal experiences of the patients. Questionnaires
that assess the patients subjectively are needed to assess
their challenges and motivation for treatment [2].
The Zurich Chronic Middle Ear Questionnaire
(ZCMEI-21) is a newly-developed German-language

questionnaire that comprehensively evaluates the
symptoms and psychosocial effects of health-related
quality of life (HRQoL) in COM patients [3]. The English,
German, and Italian versions were found to be valid and
consistent; however, English, German, and Italian belong
to the Indo-European language family. Validation of a
Japanese language version was performed and found to be
suitable [4–6]. Japanese is from the Ural-Altaic language
family, like Turkish, and has a similar structure. However,
the only ear disease-related questionnaire translated into
Turkish was the chronic otitis media questionnaire-12
(COMQ-12), which only briefly mentions lifestyle
effects and is heavily oriented around hearing-related
impairment of HRQoL [7]. Therefore, there is a need for a
measurement to evaluate patients more comprehensively.
In this study, the aim was to translate the ZCMEI-21
into Turkish and evaluate its cross-cultural adaption and
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validation in order to assess the quality of life (QoL) of
patients with COM.
2. Material and methods
2.1. Patients
Ethical permission approval was obtained from the Ethics
Committee of our institution under approval number
48670771-000-8112. Informed consent form was given by
all of the participants.
2.2. Inclusion criteria
Preoperative and postoperative patients with preoperative
or postoperative COM simplex (OMCS) or COM with
cholesteatoma (OMCC) who were older than 18 years old
were invited to participate in the study. The control group
included patients with no ear complaints.
2.3. Translation and cross-cultural adaptation
Translation from German to Turkish was completed
by 2 professional translators. These 2 inventories were

then combined into a single file by physicians and
translators (ZCMEI-21-Tur, v1). This first version was
applied to 5 patients. The problems that the patients
had in understanding the questions were evaluated,
and minor changes were made (ZCMEI21-Tur, v2). A
third professional translation agent then did a German
translation of the final version, and the ZCMEI-21-Tur
was changed into a conceptually equalized translation
(ZCMEI-21-Tur, v3). The second pilot test (cognitive
questioning 2) was performed with another 5 COM
patients. No changes were made. The final version of the
questionnaire (ZCMEI-21-Tur) was applied to both groups
of patients and healthy volunteer subjects (Figure 1).
2.4. Validation
The original German questionnaire was administered
to patients via an electronic version. The patients
were interviewed face-to-face and administered the
questionnaire in person. The questionnaires (ZCMEI-21-

Figure 1. Flow chart of the translation and validation approach.
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Tur and EQ-5D-5L) were administered by a single resident
to 84 patients who met the inclusion criteria and to 40
healthy volunteers. Of the patients, 4 were excluded from
the study due to incomplete questionnaires. Question 22,
which was in the original validation study, was included
in the questionnaire. This was a general question that
addressed HRQoL directly: “The disease in my ear worsens
my quality of life”.
The EQ-5D-5L version consists of 5 main questions,
and each question has 5 answers. The 5 questions cover
the mobility of the patient, self-care, daily activities, and
pain/discomfort related to COM, and anxiety/depression
caused by disease [8]. Patients choose from 1- to 5-point
Likert-type appropriate responses. It also includes a visual
analog scale (VAS) score. This VAS is based on describing
their health status on a scale from 0 to 100, with 100
corresponding to the best health condition. The survey
was completed by 120 people and the survey results were
evaluated statistically.
2.5. Statistical analysis
Values were reported as the mean ± SD or as an absolute
number and percentage. The item total-correlation was
calculated in order to evaluate whether it correlated with
the total score. An item total-correlation of ≥0.3 indicated
that a question correlated well with the total score and
represented 1 criterion for a strong item. Construct
validity was established using a question (question 22)
that directly assessed HRQoL. For assessing the reliability
of the ZCMEI-21-Tur, internal consistency, as an indicator
of reliability, was determined using the Cronbach α.
Concurrent validity was determined by comparing the
ZCMEI-21-Tur total scores and subscores to the EQ-5D
descriptive system and VAS scores using the Spearman

rank correlation and linear regression analysis, including
mean prediction intervals. Statistical significance was
accepted as P < 0.05.
3. Results
A total of 80 patients and 40 controls completed the ZCMEI21-Tur and EQ-5D-5L. Thus, a total of 120 participants,
with a mean age of 30.4 ± 9.2 (between 18 and 45) years
in the validation group and 29.9 ± 8.9 (18–44) years in the
control group, were included in the study. OMCC was the
diagnosis in 29 (36%) patients and OMCS was seen in 51
(64%) patients. At the time of fulfillment of the ZCMEI21-E, 62 (78%) patients had already undergone surgery
for COM. Additionally, 40 had undergone tympanoplasty
and 22 had tympanomastoidectomy. The air conduction
threshold of the patients was 46.3 ± 8.2 dB HL, and the
bone conduction threshold was 26.6 ± 6.9 dB HL. The air
conduction threshold of the control group was 15.6 ± 6.1
db HL, while the bone conduction threshold was 9.5 ± 4.5
dB HL. Detailed characteristics of the patients and control
group are given in Table 1.
Concerning the single-item descriptive statistics of the
ZCMEI-21-Tur, it was found that the answers were well
distributed and the full range of answers was used on every
question. Item-total correlations of all of the items were
well above 0.3 (for detailed descriptive statistics, see Table
2). An item-total correlation of ≥0.3 indicated that an item
correlated well with the total score, representing 1 criterion
for a strong item. Assessing the internal consistency as
an indicator of reliability, the questionnaire showed a
Cronbach α of 0.94, indicating high internal consistency.
Adequate to excellent internal consistency was also found
for the individual subscales (Table 2).

Table 1. Patient characteristics of the study population and control group.
Validation group
(n = 80)

Controls
(n = 40)

Male to female ratio

38:42

19:21

Age (mean ± SD) (years)

30.36 ± 9.22

29.87 ± 8.93

COM, type—no. (%)

N/A

OMCC

29 (36 %)

OMCS

51 (64 %)

Affected ear(s)—no. (%)

N/A

Right

48 (60 %)

Left

29 (36 %)

Both

3 (4 %)

Previous operation due to COM—no. (%)

62 (78 %)

N/A

COM, chronic otitis media; OMCS, otitis media chronica simplex; OMCC, otitis media
chronica cholesteatomatosa.
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Table 2. Descriptive statistics of the individual items (ZCMEI-21-Turkish).
Mean

SD

Min–max ITC

I. Ear signs and symptoms

Cronbachα
0.79

1. Ear pain

1.00

0.81

0–3

0.66

2. Discharge

0.65

0.81

0–3

0.75

3. Itching

0.90

1.00

0–4

0.42

4. Feeling of pressure

0.84

0.74

0–2

0.60

5. Balance

0.43

0.63

0–2

0.48

II. Hearing

0.83

6. Tinnitus

1.46

1.42

0–4

0.48

7. Hearing (filter question)

1.84

1.01

0–4

0.67

8. When many people speak at the same time

1.65

1.06

0–4

0.70

9. Telephone, alarm clock

1.81

1.26

0–4

0.65

10. Fear of not hearing other people

1.53

1.12

0–4

0.64

11. Impact of ear symptoms on HRQoL

1.96

1.35

0–4

0.81

12. Protection from water

1.00

1.30

0–4

0.55

13. Activities with family and friends

1.78

1.34

0–4

0.74

14. In public (e.g., school/occupation, shopping)

1.35

1.03

0–4

0.67

15. Making contact with other people

1.60

1.34

0–4

0.79

16. Quality of sleep

2.89

1.38

0–4

0.79

17. Sadness

2.85

1.18

0–4

0.71

18. Fear that the ear problems may persist

1.73

1.11

0–4

0.63

19. Medical consultations

1.68

0.99

0–4

0.71

20. Antibiotics (oral)

1.26

1.06

0–3

0.75

21. Ear drops

1.75

1.17

0–4

0.64

III. Psychosocial impact

0.91

IV. Medical resources

0.84

ITC: item total correlation; min: lowest value; max: highest value; α: Cronbach α for the subscales.

When comparing the total score and direct HRQoL
question, a strong correlation (r = 0.69, P < 0.001) was
found. When comparing the ZCMEI-21-Tur total score
and EQ-5D scores, strong correlations (r = 0.76, P < 0.001
for the descriptive system score and r = 0.70, P < 0.001 for
the VAS score) were found. The total score of the ZCMEI21-Tur and the scores of its subscales, comprising ear signs
and symptoms (questions 1–5), hearing (questions 6–10),
psychosocial impact (questions 11–18), and medical
resources (questions 19–21) are given in Table 3 and
Figures 2, 3A–3C, and 4A–4C).
Because a significant portion of the validation group
had already undergone surgical treatment for COM (78%),
the differences between the ZCMEI-21-Tur total scores of
the patients who had undergone surgery and those who
had not undergone surgery were assessed. The mean
ZCMEI-21-Tur score patients who had undergone surgery

was 29.0 ± 8.4 and for those who had not undergone
surgery it was 41.9 ± 12.8 (P < 0.001). The results of the
comparison of the ZCMEI-21-Tur scores between the
patients with COM and the control group are given in
Table 4. The patients had higher mean total scores and SDs
when compared to the control group (P < 0.001).
4. Discussion
In recent years, patient-reported outcome measures
(PROMs) have become of great importance for followup, evaluation, and research [9]. There are 3 commonly
used questionnaires for PROMs in adult patients with
COM, comprising the chronic ear survey (CES, English),
Chronic Otitis Media Outcome Test-15 (COMOT-15,
German), and COMQ-12 (English) [10]. Each survey
highlights a different area. In this study, the ZCMEI-21
was successfully translated into Turkish and validated.
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Table 3. Comparison and correlation of the total scores and subscales scores of the ZCMEI-21 and ZCMEI-21-Turkish and
EQ-5D-5L.
Current study
ZCMEI-21-Turkish (n = 80)

Original validation study
ZCMEI-21 (n = 76)

ZCMEI-21-Turkish/ZCMEI-21 total score (±SD)

31.9 ± 10.9

29.7 ± 16.1

I. Ear signs and symptoms

3.8 ± 2.8

5.1 ± 3.9

II. Hearing

8.3 ± 3.4

8.5 ± 5.2

III. Psychosocial impact

15.2 ± 6.1

13.1 ± 7.9

IV. Medical resources

4.7 ± 2.5

3.0 ± 2.3

Descriptive system score

0.90 ± 0.13

0.92 ± 0.14

VAS score

74.8 ± 16.8

N/A

To question directly assessing HRQoL (Q22)

r = 0.69, P ˂ 0.001

r = 0.74, P ˂ 0.001

To EQ-5D-5L descriptive system score

r = 0.76, P ˂ 0.001

r = 0.60, P ˂ 0.001

To EQ-5D VAS score

r = 0.70, P ˂ 0.001

N/A

EQ-5D-5L (±SD)

Total score correlation*

*Spearman’s rank correlation coefficient, P-value.

Figure 2. Spearman’s rank correlation of the ZCMEI-21-Turkish total scores and the
question directly addressing HRQoL (0 on the x-axis corresponds to no impact on
HRQoL, as indicated by the question directly addressing HRQoL, whereas 4 indicates
the greatest impact; Spearman’s rank correlation.

The CES was developed by Nadol et al. in 2000 and
contains 13 questions on 3 main topics: activity restriction,
symptoms, and medical resources. It does not include
questions about tinnitus or dizziness, and it also does not
evaluate the psychology or decrease in QoL of the patient
[1,10]. The COMOT-15 was introduced by Baumann et
al. in 2009. It includes questions about ear symptoms,
hearing, and mental status. It does not inquire about
anxiety, depression, or social isolation, which have specific
importance in COM [11,12]. The COMQ-12 questionnaire
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was developed in 2014 by Phillips et al. It contains 12
questions in 4 categories, comprising symptoms, lifestyle
and work, healthcare, and general impact. Although it
contains questions about impact on lifestyle and work, it
does not include questions that meet the psychological
and social dimensions of COM [13].
In 2016, Bächinger et al. [3] developed a new German
electronic questionnaire, ZCMEI-21, for the comprehensive
measurement of HRQoL, which aimed to evaluate
adult COM patients in all aspects of the disease and its

TUTAR et al. / Turk J Med Sci

Figure 3. (A–C) Spearman’s rank correlation between the ZCMEI-21-Turkish subscale scores and EQ-5D descriptive systems score.
Solid line represents linear regression, dashed lines represent 95% prediction intervals. A) r = 0.71, P ˂ 0.001. B) r = 0.69, P ˂ 0.001. C)
r = 0.65, P ˂ 0.001.

consequences on HRQoL. Although the ZCMEI-21 is based
on current surveys (CES, COMOT-15), it varies in several
aspects that provide certain advantages. The ZCMEI-21
evaluates classic ear symptoms (e.g., pain, discharge,
dizziness/balance problems, hearing impairment, and
tinnitus). The pain-related element is particularly important
concerning patients who have recently undergone surgery.
The ZCMEI-21 is classified into 4 subheadings: I) ear signs
and symptoms, II) hearing, III) psychosocial effects, and
IV) medical resources. Regarding the psychological and
social aspects of the patients, the ZCMEI-21 is valuable
in the evaluation of neglected aspects of the disease.
Baechinger et al. administered the ZCMEI-21 to 76 patients
with COM. They compared the total score of the ZCMEI-21
with a question that directly reflected HRQoL and the
total score of the EQ-5D questionnaire. The ZCMEI-21
total score and EQ-5D descriptive system score were only
moderately correlated (r = 0.60, P < 0.0001), while the
ZCMEI-21 total score and the question directly related to

HRQoL showed a strong correlation (r = 0.74, P < 0.0001).
Verification showed a Cronbach α of 0.91 and excellent
internal consistency. In addition, the ZCMEI-21 was able to
differentiate patients with COM from healthy participants
(P < 0.0001). Thus, good sensitivity was obtained. As a
result, sufficient information was obtained about reliability
and validity to extend the application of the ZCMEI-21 to
quantify HRQoL in patients with COM.
The current study of the ZCMEI-21-Tur revealed a
Cronbach α of 0.94, indicating higher internal consistency
than the Japanese and English versions. Adequate to
excellent internal consistency was also found for the
individual subscales. When comparing the ZCMEI-21Tur total score and the question directly assessing HRQoL,
a strong correlation (r = 0.69, P < 0.001) was detected.
When comparing the ZCMEI-21-Tur total score and the
EQ-5D scores, strong correlations were obtained (r = 0.76,
P < 0.001 for the descriptive system score and r = 0.70, P <
0.001 for the VAS score).

1927

TUTAR et al. / Turk J Med Sci

Figure 4. (A–C) Spearman’s rank correlation between the ZCMEI-21-Turkish subscale scores and EQ-5D VAS score. Solid line represents
linear regression, dashed lines represent 95% prediction intervals. A) r = 0.48, P ˂ 0.001. B) r = 0.68, P ˂ 0.001. C) r = 0.64, P ˂ 0.001.
Table 4. Comparison of the ZCMEI-21-Turkish scores between patients with COM and healthy
participants serving as the controls (mean ± SD, Mann–Whitney U test).
COM (validation group)

Controls

P-value

I. Ear signs and symptoms

3.8 ± 2.8

0.7 ± 0.5

˂0.001

II. Hearing

8.3 ± 3.4

0.0 ± 0.0

˂0.001

III. Psychosocial impact

15.2 ± 6.1

0.0 ± 0.0

˂0.001

IV. Medical resources

4.7 ± 2.5

0.0 ± 0.0

˂0.001

Total score

31.9 ± 10.9

0.7 ± 0.5

˂0.001

There were some limitations of the study, including the
limited number of participants and heterogeneous COM
group. Both preoperative and postoperative patients were
included the study, which may have seemed confusing, but
the original paper, English, and Japanese validations were
designed to include both; hence the current study did as
well. On the other hand, the total number of participants
was sufficient to perform the statistical analysis.
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Conclusion: The ZCMEI-21-Tur is suitable for use
in assessing HRQoL in adult patients with COM. It may
therefore be used for following-up patients for research
purposes, as well as in clinical practice.
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